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Abstract
Background: Osteoarthritis (OA) of the hip is a major cause of functional disability and reduced quality
of life. Management options aim to reduce pain and improve or maintain physical functioning. Current
evidence indicates that therapeutic exercise has a beneficial but short-term effect on pain and disability,
with poor long-term benefit. The optimal content, duration and type of exercise are yet to be ascertained.
There has been little scientific investigation into the effectiveness of manual therapy in hip OA. Only one
randomized controlled trial (RCT) found greater improvements in patient-perceived improvement and
physical function with manual therapy, compared to exercise therapy.
Methods and design: An assessor-blind multicentre RCT will be undertaken to compare the effect of a
combination of manual therapy and exercise therapy, exercise therapy only, and a waiting-list control on
physical function in hip OA. One hundred and fifty people with a diagnosis of hip OA will be recruited and
randomly allocated to one of 3 groups: exercise therapy, exercise therapy with manual therapy and a
waiting-list control. Subjects in the intervention groups will attend physiotherapy for 6–8 sessions over 8
weeks. Those in the control group will remain on the waiting list until after this time and will then be re-
randomised to one of the two intervention groups. Outcome measures will include physical function
(WOMAC), pain severity (numerical rating scale), patient perceived change (7-point Likert scale), quality
of life (SF-36), mood (hospital anxiety and depression scale), patient satisfaction, physical activity (IPAQ)
and physical measures of range of motion, 50-foot walk and repeated sit-to stand tests.
Discussion: This RCT will compare the effectiveness of the addition of manual therapy to exercise
therapy to exercise therapy only and a waiting-list control in hip OA. A high quality methodology will be
used in keeping with CONSORT guidelines. The results will contribute to the evidence base regarding the
clinical efficacy for physiotherapy interventions in hip OA.
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Background
Osteoarthritis can be defined as a group of overlapping
distinct diseases, which may have different aetiologies but
with similar biologic, morphologic and clinical outcomes.
The articular cartilage degenerates with the development
of fibrillation and fissures, and full thickness loss of the
joint surface' [1]. It is estimated that by 2030 the propor-
tion of people with OA will have risen from 20% to 30%
in those aged 60 years or over [2]. Increasing life expect-
ancy, decreasing physical activity, and increasing body
weight are all considered as underlying factors. OA is the
most common form of arthritis and is associated with a
considerable cost to the individual and to society. A World
Health Organisation report identified OA as the 8th lead-
ing cause of non-fatal burden in the world in 2000,
accounting for 2.6% of total years lost due to disability
[3]. It is commonly associated with other medical condi-
tions such as cardiovascular disease, respiratory disease
and diabetes [4,5]. Prevalence of hip OA varies between
1.4% and 3.5% based on radiographic definitions [6], and
between 0.7 and 4.4% for symptomatic hip OA [7]. Phys-
ical function and physical activity levels are reduced in hip
OA and consequently this can impact on quality of life [8-
10] and has associated psychosocial impact such as
depression [11-13].
To date, there is no cure for OA, so the principles of man-
agement are to control pain, improve function and reduce
disability [14,15]. Contemporary thinking is that non-
pharmacological measures such as patient education,
weight loss, physiotherapy, occupational therapy, and
exercise should be tried first, with pharmacological inter-
vention used as an adjunct [16]. Physiotherapy is the most
common non-pharmacological intervention prescribed
for OA [17] and aims to reduce pain and restore or main-
tain optimum physical functioning [18].
Physiotherapy can comprise a number of different inter-
ventions, including electrotherapy, massage and the pro-
vision of orthotics, but a questionnaire survey of Irish
physiotherapists in public and private settings identified
that the most common interventions used by physiother-
apists to manage hip OA were exercise therapy (100%),
education (99%) and manual therapy (96%) [19].
Evidence for Exercise Therapy
Therapeutic exercise has been recommended as a key
component of the management of hip OA in a number of
clinical guidelines [20-24]. It can comprise joint-specific
exercise for range of motion, strengthening of muscles
around the hip and general aerobic conditioning. It can
take place on land or in water (hydrotherapy) and can be
done in a supervised setting or as a home-based self-
directed programme [25]. A number of studies have eval-
uated the effect of exercise therapy in hip OA. Different
forms of exercise therapy have been investigated such as
hydrotherapy [26-30] and strengthening [29,31-34]. Exer-
cise has also been used as a control intervention with the
provision of advice/education and a programme of home
exercises [28,35].
Although a number of systematic reviews have been
undertaken evaluating the effectiveness of exercise ther-
apy in OA, most of these have included knee and hip OA
studies [36-39], with just one focussing specifically on hip
OA [40]. This review, based on nine RCTs, found that
therapeutic exercise, with a strengthening component,
was an efficacious treatment for pain in hip OA. To date,
the benefits of exercise for improving pain and function in
hip OA appear to be short-term only [32,34,38] However,
many of the studies undertaken have combined hip and
knee OA patients [29,30,32,41] thereby limiting the value
of the results. These studies were not powered sufficiently
to observe the effect of exercise on hip OA only. Secondly,
the same exercise regime was used by patients with hip
and knee OA, thus the specificity of the exercise regime to
hip OA is questionable. Certain flaws existed in many of
the studies such as inadequate sample size [29,34], lack of
intention-to-treat analysis [41,42] and lack of blinding of
outcome assessors [29,42]. Due to the nature of exercise
based interventions, blinding of the subjects and treating
therapists was not possible in any of the studies [43].
Evidence for Manual Therapy
Manual therapy is a commonly used intervention in the
management of musculoskeletal dysfunction in physio-
therapy. It can be defined as 'a clinical approach involving
specific hands-on techniques including, but not limited to
specific hands-on mobilization, that are used by the phys-
ical therapist to diagnose and treat soft tissues and joint
structures for the purpose of modulating pain; increasing
range of motion; reducing or eliminating soft tissue
inflammation; inducing relaxation; improving repair,
extensibility or stability of contractile or non-contractile
tissue; facilitating movement and improving function'
[44] (pg 180). Manual therapy comprises manipulation
and mobilisation techniques. Manipulation consists of
forceful, high velocity thrusts, whilst mobilisations are
less vigorous techniques which are used more often than
manipulation for peripheral joint pain and stiffness [17].
Despite its widespread use clinically, there is little scien-
tific evidence to substantiate the effectiveness of manual
therapy in reducing pain or improving function in OA
[45]. Specifically in hip OA, there has been considerably
less research into the effectiveness of manual therapy
compared with exercise therapy.
To these authors' knowledge, only one clinical trial has
been conducted evaluating manual therapy in hip OA
[33]. Manual therapy, which encompassed manipulation
BMC Musculoskeletal Disorders 2009, 10:9 http://www.biomedcentral.com/1471-2474/10/9
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techniques and stretching, was compared head to head
against exercise therapy. Results at 5 weeks demonstrated
81% improvement in the manual therapy group and 50%
in the exercise therapy group. This was based on a 6-point
Likert scale of patient perceived general improvement.
These data may not be relevant to clinical practice in Ire-
land for two reasons. Firstly, in Ireland, therapists more
commonly use mobilization techniques developed by
Mulligan [46] and Maitland [47] rather than manipula-
tion [19]. Secondly, current clinical practice shows that
manual therapy is frequently used in combination with
other interventions such as exercise therapy [19] and there
is a need to conduct randomized controlled trials that are
transferable to clinical practice [48]. To date, no known
studies have evaluated the combined effect of manual
therapy and exercise in hip OA. Recently published UK
clinical guidelines on the care and management of oste-
oarthritis in adults recommended manual therapy as an
adjunctive treatment to core treatments of exercise and
education in OA, particularly hip OA [20].
Predictors of response to treatment
Treatment effectiveness can be improved by matching
treatment to patient characteristics to determine what
works best for whom. Few studies have evaluated predic-
tors of response to physiotherapy in hip OA. Hoeksma et
al [49] found that patients with mild/moderate radio-
graphic changes who received manual therapy had signif-
icantly better range of motion outcomes than those with
severe changes. Manual therapy had no differential effect
on subgroups of patients defined by baseline pain or hip
function. This secondary analysis did not evaluate the out-
come of the exercise intervention on different subgroups.
Female gender, low co-morbidity, absence of depressive
symptoms and a history of receiving complementary
medicine in the previous 12 months were the most stable
predictors of outcome in a non-randomised study of inpa-
tient rehabilitation for hip or knee OA [50]. In this pro-
posed study, patients of varying severity will be included
and it is possible that treatment effects may be different in
groups of patients with different characteristics, such as x-
ray severity and symptomatic severity.
In summary, a multi-centre randomised controlled trial
that compares the clinical effectiveness of a combination
of manual therapy and exercise therapy, exercise therapy
only and a waiting-list control will be conducted. This
study also will examine if any clinical baseline features
predict response to treatment as a secondary analysis.
Methods
Aim
The primary aim of this study is to compare the effect of a
combination of manual therapy and exercise therapy,
exercise therapy only and a waiting-list control on physi-
cal function in hip OA.
A secondary aim of the study will be to investigate the
effect of baseline variables such as age, gender, body mass
index, disease severity, baseline pain, physical function,
mood and co-morbidities on treatment outcome.
Study Design
A multi-centre assessor blind RCT that evaluates the clini-
cal effectiveness of two physiotherapy interventions for
patients with osteoarthritis of the hip will be conducted.
The methodology will follow CONSORT (Consolidation
of Standards of Reporting Trials) guidelines [51,52].
Ethics
Ethical approval for this study has been granted by the
research ethics committees of the four participating hospi-
tals: St James' Hospital/Adelaide Meath Hospital Dublin,
incorporating the National Children's Hospital research
ethics committee, Beaumont hospital ethics medical
research committee, St Vincent's Healthcare Group Ltd
ethics and medical research committee and Mater Miseri-
cordiae University Hospital research ethics committee.
Participants
Potential participants will be recruited from the physio-
therapy waiting lists in the four participating hospitals if
they meet the inclusion criteria as shown in Table 1.
Recruitment Procedure
All patients with a diagnosis of hip OA referred for physi-
otherapy from rheumatologists, GPs, orthopaedic con-
sultants and other hospital consultants will be considered
for inclusion in the RCT. Four physiotherapy departments
in large acute hospitals in the Dublin area will be used:
Beaumont Hospital, St Vincent's University Hospital,
Adelaide Meath Hospital Dublin, incorporating the
National Children's Hospital and Mater Misericordiae
University Hospital.
Patients will be initially contacted by letter to explain the
purpose of the study. A copy of the participant informa-
tion leaflet will be enclosed. An initial telephone screen-
ing interview will be conducted to screen for major
exclusion criteria and to provide the participant with
more detailed information about the study. Potentially
suitable participants will then be invited to attend an
appointment with the blinded outcome assessor (HPF)
who is a qualified physiotherapist. At this time, a compre-
hensive musculoskeletal examination will be undertaken
to verify the volunteer's suitability for inclusion, based on
the inclusion criteria outlined in Table 1. If eligibility is
confirmed, patients will complete the consent form.
BMC Musculoskeletal Disorders 2009, 10:9 http://www.biomedcentral.com/1471-2474/10/9
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Randomisation
Two computer generated randomisation lists have been
drawn up by a statistician who is independent of the
study. The first list will be used to randomize participants
into one of the three arms of the trial. The second list will
be used to re-randomise those subjects in the control
group into one of the two intervention groups after the 9
week follow-up assessment. Both lists will be maintained
by a member of the research team (TC) who will not be
involved in the assessment or treatment of the partici-
pants.
Once informed consent has been obtained and baseline
outcome measures have been completed, each participant
will be randomly allocated to one of 3 groups
a. Exercise therapy
b. Exercise therapy and Manual Therapy
c. Control group (Waiting List)
Simple randomisation will be conducted. Group alloca-
tion will be communicated to the treating therapists in
each treatment centre by the independent randomiser.
Interventions
Interventions will be administered by senior chartered
physiotherapists in the four participating hospitals. All
treating therapists will have attended two training ses-
sions which will focus on the exercise and manual therapy
interventions to ensure a standardised approach to treat-
ment across the four trial centres.
The three components of the trial are as follows:
Exercise therapy
Participants will attend six to eight 30 minute physiother-
apy sessions over eight weeks. Each treatment will be
administered on a one to one basis. The exercise interven-
tion will incorporate flexibility and strengthening exercise
using a semi-structured protocol, which provides guid-
ance on exercise prescription and progression, but can be
tailored to individual patient physical assessment find-
ings. The content of the protocol is based on the findings
of a questionnaire survey of the practice of Irish physio-
therapists in the management of hip OA [19] and clinical
guidelines for the management of hip and knee OA
[21,24,54,55]. The focus of the strengthening programme
is based on low load exercise, commencing in non weight
bearing positions and progressing to functional positions
[54]. The key target muscles are the gluteal muscles which
are commonly atrophied in hip OA [56-58]. A range of
exercises to address the various degrees of severity of hip
OA will be available. Patients will also undertake a daily
home exercise programme to supplement the clinic based
treatment. They will complete an exercise log which will
be reviewed by the treating therapist at each clinic attend-
ance.
Each subject will be encouraged to undertake some form
of aerobic exercise (such as walking, cycling, swimming)
over the intervention period. They will be given written
and verbal information on principles of aerobic condi-
tioning such as pacing, gradually progressing intensity
and time of exercise, doing 'little and often' and incorpo-
rating exercise into daily life. They will also be advised of
Table 1: Inclusion/Exclusion Criteria
Inclusion Criteria
1. Subjective complaint of hip pain with either hip internal rotation
< 15° and hip flexion <115° or
2. ≥15° hip internal rotation and pain on hip internal rotation, morning stiffness less than or equal to 60 minutes, age > 50 years.
(American College Rheumatology Clinical criteria for the diagnosis of hip osteoarthritis) [53]
3. Age 40–80 years except in 2 above (age >50 years).
4. Radiological evidence of osteoarthritis (2 of the following 3 criteria): osteophytes, joint space narrowing, ESR<20 mm/hr.
(American College of Rheumatology Criteria for the Classification and Reporting of Osteoarthritis of the Hip) [53].
Exclusion Criteria
1. Previous hip arthroplasty, history of congenital/adolescent hip disease
2. Clinical signs of lumbar spine disease
3. Physiotherapy in previous 6 months
4. Pregnancy
5. Hip fracture
6. Contraindications to exercise therapy (unstable angina/blood pressure, myocardial infarction in previous three months, cardiomyopathy, 
uncontrolled metabolic disease, recent ECG changes, advanced COPD, third degree heart block)[54]
7. On waiting list for joint replacement within the next 27 weeks
8. Rheumatic diseases e.g. Rheumatoid Arthritis, Ankylosing Spondylitis, etc.
9. Intra-articular hip corticosteroid injection in previous 30 days
10. Insufficient English language to complete questionnaires
BMC Musculoskeletal Disorders 2009, 10:9 http://www.biomedcentral.com/1471-2474/10/9
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cardiovascular warning symptoms/signs to be aware of,
which may require review by a medical practitioner. Par-
ticipants will be encouraged to achieve recommended aer-
obic exercise target of at least 30 minutes, five days a week
[59].
Exercise Therapy and Manual Therapy
Participants in this group will attend six to eight 45
minute sessions of physiotherapy over an eight week
period. This will include 30 minutes of exercise therapy
and 15 minutes of manual therapy. A choice of manual
therapy techniques can be used which will be based on
the pain/stiffness relationship as well as the movement
restrictions of the affected hip. These will be ascertained
by the blinded outcome assessor to ensure standardiza-
tion and will be communicated to the treating therapists
on a referral form. Treating therapists may choose from a
list of manual therapy techniques based on Maitland [47],
Mulligan [46], Cyriax [60] and other mobilization tech-
niques such as muscle energy techniques [61] and propri-
oceptive neuromuscular facilitation (PNF)[62].
Control Group (Waiting List Control)
Participants in the control group will continue to wait on
the physiotherapy waiting list for an eight week period.
On the 9th week, they will complete a follow-up assess-
ment with the blinded outcome assessor. They will then
be re-randomised into one of the two intervention groups.
All groups will receive standardized written information
on hip OA as recommended by clinical guidelines [22]
including a standardised educational booklet entitled
'Osteoarthritis: helping you to understand osteoarthritis'
and 'Osteoarthritis-Questions and Answers' published by
Arthritis Ireland. This will ensure that education is not a
confounding variable in the study.
All non-consenting and excluded participants will be
treated as usual by the physiotherapy department of each
trial centre. Participants will be asked to avoid all other
forms of intervention for the duration of the RCT, apart
from routine doctor care and analgesics. Participants with
bilateral hip OA will receive treatment for both hips, but
outcomes will be assessed on the worst affected hip only.
Outcome Measures
Patients will be assessed at baseline, 9 weeks (end of treat-
ment for the intervention groups) and 18 weeks (end of
treatment for the control group) by the blinded assessor in
the physiotherapy department of each hospital. Subjects
in the control group will have an additional follow-up at
27 weeks (18 weeks post treatment) (Fig 1). Subjects and
treating therapists cannot be blinded to treatment alloca-
tion due to the nature of the interventions.
Standardised instruments with proven validity and relia-
bility and in keeping with the core set of outcome meas-
ures of pain, physical function and global assessment as
recommended by OMERACT III (Outcome measures in
Rheumatology Group) [63] for use in osteoarthritis will
be used. All outcomes will be measured at baseline, 9, and
18 weeks (and 27 weeks for the control group), unless
otherwise stated.
The primary outcome measure will be:
WOMAC (Western Ontario and McMaster Universities) 
Osteoarthritis Index Physical Function Subscale
The WOMAC is a multidimensional, self-administered
health status instrument. It is available on both a 5-point
Likert scale and a 100 mm visual analogue scale (VAS). In
this study, the Likert version will be used. WOMAC con-
sists of 24 questions regarding pain (scored 0–20), stiff-
ness (scored 0–8) and physical function (scored 0–68). It
has been shown to be a reliable, valid and responsive mul-
tidimensional outcome measure in patients with osteoar-
thritis of the hip or knee [64] and has been found to
demonstrate superior responsiveness to the Lequesne
Algofunctional Index [65]. Minimal perceptible clinical
improvement has been found to be 9.3 mm on the phys-
ical function subscale on the WOMAC 100 mm normal-
ised VAS [66].
Secondary Outcome Measures include:
Global Assessment of Change (GAC)
Patient global assessment is one of the core domains
which was recommended by OMERACT for evaluation in
phase III trials in OA [63]. GAC comprises a single ques-
tion which asks participants about the degree of change
since their previous assessment and is therefore retrospec-
tive or transitional in nature. It functions as an external
criterion to differentiate between changed and unchanged
patients at the end of the study. It is subject to recall bias
and can be heavily influenced by current status and
patient satisfaction [67]. A 7-point Likert scale will be
used ranging from 'very much worse' to 'very much better',
with 'no change' located in the middle. The minimal clin-
ically important difference of an average change of 0.5 on
a 7-point scale has been found [68,69]. This will be meas-
ured at 9 and 18 weeks (and 27 weeks for the control
group).
Numerical Rating Scale (NRS) for Pain Severity
This is an 11-point scale that measures pain severity. Sub-
jects will be asked to rate pain severity in the previous 24
hours with activity, at night and at rest. It is reliable, valid
and preferable to a visual analogue scale in pain measure-
ment, especially in an older population [70,71]. A change
BMC Musculoskeletal Disorders 2009, 10:9 http://www.biomedcentral.com/1471-2474/10/9
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Flow of participants through the RCTigure 1
Flow of participants through the RCT.
Exercise Therapy 
(n=50) 
Combined Exercise and 
Manual Therapy (n=50) 
Wait list control  
(n=50) 
9 week outcome assessment (Blinded Assessor) 
18 week outcome assessment (Blinded Assessor)  
(9 week post treatment in control group) 
Exercise 
Therapy 
(n=25) 
Combined 
Exercise and 
Manual Therapy 
(n=25) 
Re-randomise
27 Week Outcome Assessment  
(18 week post treatment in control group) 
Baseline Outcome Assessment (0 weeks) 
Physical Screening (to verify inclusion/exclusion criteria) 
Informed Consent 
Telephone Screening (for major exclusion criteria) 
Randomised by independent team member 
Identification of potentially suitable participants from physiotherapy 
waiting list 
Physiotherapy 
as normal  
Physiotherapy 
as normal  
Exclude
Exclude
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of approximately 2 points or 30% is considered to be clin-
ically important [72].
Short Form-36
This is a widely used well validated self-completed ques-
tionnaire that measures perceived health status and qual-
ity of life. It consists of eight multi-item scales measuring
physical functioning (PF), bodily pain (BP), role limita-
tions due to physical health problems (RP), general health
(GH), vitality (V), social functioning (SF), role limitations
due to emotional problems (RE) and mental health
(MH)[73]. The scores on all subscales range from 0–100
with higher scores indicating better health status. A phys-
ical and mental health score can be derived from the
items. The SF-36 has been used in other rehabilitation
studies of hip OA [30,33,74].
Hospital Anxiety and Depression Scale (HADS)
This self-report questionnaire measures mood disorder
and is validated for use as a screening tool in the general
population [75]. It contains 14 items, 7 relating to anxiety
and 7 relating to depression, which are scored separately.
A score of 0–7 indicates no anxiety or depression, 8–10 is
borderline and 11–21 indicates the presence of anxiety or
depression [76]. Due to the strong links between OA and
psychological wellbeing [77,78], this outcome will be
used to identify if anxiety or depression are confounders
to treatment response and predictors of treatment out-
come.
International Physical Activity Questionnaire (short 
version)
This is a self-report questionnaire which asks participants
to recall the amount of physical activity undertaken over
the previous 7 days. It has been extensively validated
across 12 countries for the measurement of physical activ-
ity in adults age 18–69 years [79].
Physiotherapy Out-Patient Survey for patient satisfaction
This validated self-report questionnaire was specifically
developed to measure patient satisfaction with physio-
therapy in an outpatient setting. It measures dimensions
of expectation of physiotherapy, communication, percep-
tions of the therapist, organization of treatment sessions,
content of treatment session and outcome of treatment
[80]. It will be completed at the 18 week follow-up assess-
ment only.
Pain Medication Usage (Pain Diary and Medication 
Quantification Scale (MQS))
Medication usage is a central management strategy in OA
[15,20] and it is therefore important to measure the
potential change in this usage over the course of the RCT.
The MQS is an established, partially validated instrument
that quantifies pain medication usage over a period of
time. Each pain-related medication that participants are
taking is given a score that is derived by multiplying the
detriment weight of the drug and the relative daily dosage
[81]. A single score is calculated that can be compared at
different points in time and includes weighting for detri-
mental effects of the medication [82]. The daily dosage of
pain medications will be measured using a medication
diary which the participants will record over a 7 day
period.
Hip Range of Motion
Loss of range of motion (ROM) is a common clinical find-
ing in hip OA and is associated with pain and disability
[83]. Active range of motion will be measured on the
affected hip. The movements of flexion, abduction,
medial rotation and Thomas test will be measured using a
universal goniometer. High test-retest reliability values for
flexion, abduction and medial rotation have been
reported (0.82, 0.86 and 0.90 respectively using the intra-
class correlation co-efficient (ICC)) in subjects with hip
OA [84]. A combined movement of flexion, abduction
and external rotation (FABER) or the Patrick test will be
measured using a measuring tape. This has been found to
have a high test-retest reliability (ICC = 0.93) in healthy
college-aged men [85] and a high correlation with radio-
graphic changes in hip OA (Pearson's r = 0.54, p < 0.01).
It is recommended for assessment of secondary endpoints
in clinical trials [86].
Physical Performance
Physical performance measures should be used in combi-
nation with self-report measures in the assessment of
physical function [87]. In this study, two measures of
physical performance will be used.
Repeated Sit to stand
This is one of a battery of measures used by Simmonds et
al [88] to measure physical performance in subjects with
chronic disorders. The task uses a standard armchair and
requires the patient to stand from a sitting position and,
as fast as possible, to return to the seated position 5 times.
The task is repeated after a brief pause and the average
time of 2 tasks is the resulting score. The average of 2 trials
is necessary for acceptable reliability [89]. It has demon-
strated excellent test-retest reliability (ICC = 0.83) and day
to day retest reliability (ICC = 0.89) in 48 healthy pain-
free subjects [89]. It has been used as an outcome measure
in other OA studies [42,90].
50 foot walk test
The 50 foot walk test is also one of the battery of physical
performance tests used by Simmonds et al [88]. Subjects
are asked to walk at their fastest speed along a premarked
walk way of 25 feet, turn and return to the starting point.
It has demonstrated test-retest reliability of ICC = 0.91
BMC Musculoskeletal Disorders 2009, 10:9 http://www.biomedcentral.com/1471-2474/10/9
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and day to day retest reliability of ICC = 0.65 in control
subjects and ICC of 0.99 and 0.80 in low back pain sub-
jects [89]. It has previously been used in a exercise-based
osteoarthritis trials [91-93].
Sample Size Considerations
The primary outcome measure-WOMAC physical func-
tion subscale- has been used to estimate the sample size
required. The minimum clinically important difference
(MCID) has been ascertained [66]. Using an MCID of 5.4
(SD = 11) on WOMAC Likert scale, with a significance
level of 0.05 (2 tailed) and a power of 80%, it is estimated
that 67 patients are required per group. To allow for 10%
attrition at the 9 week follow-up, it is estimated that 74
patients will be required per group. However, as the wait-
ing list control group will be re-randomised into 2 treat-
ment groups after the 9 week follow-up, 50 patients per
group will be required to give a total sample size of 150
patients.
Statistical Analyses
These will be blinded and will be performed in consulta-
tion with a statistician. Baseline and demographic data
will be presented using descriptive statistics. Differences
from baseline will be calculated for all primary and sec-
ondary outcomes. Mean differences, standard deviations
and 95% confidence intervals will be calculated for all
continuous outcomes. A longitudinal repeated measures
design will be used to assess change from baseline and to
make between group comparisons for the continuous out-
come measures. Comparisons will be made between the 3
groups at the 9 week period. Participants in the control
group will be analysed according to the intervention
received after the 9 week follow-up and comparisons will
be made between the 2 intervention groups at 18 weeks
(both with and without the re-randomised control group
subjects at the 18 week period). This will be done on an
'intention to treat' basis. Participants will be analysed in
the intervention groups to which they were originally
assigned and will include withdrawels and patients not
treated by the assigned intervention. Missing data will be
replaced using the last observation carried forward. Per-
protocol analyses will also be performed by excluding
patients with deviations from the treatment protocol.
At the 9 week and 18 week time points, continuous varia-
bles will be analysed using a mixed ANOVA model (with
treatment as the between group factor and time as the
repeated factor), or the non-parametric equivalent if non-
normal distributions apply. Where significant differences
occur, post-hoc comparisons will be conducted using
Tukey's multiple comparison procedure. Differences in
nominal/ordinal data will be analysed using the χ2 test. A
significance level of 0.05 will be set for any inferential sta-
tistics conducted.
Secondary analysis will be undertaken to assess the pre-
dictors of outcome at primary endpoint (9 weeks post
treatment) in both intervention groups, using multiple
regression analyses. A number of predictor variables such
as age, gender, x-ray severity, baseline pain, physical func-
tion, mood, co-morbidities and treatment expectations
will be measured. Analyses will be performed separately
for exercise therapy, and combined exercise and manual
therapy. Response variables will be change in WOMAC
physical function score pre and post intervention (MCID>
5.4) and Global Assessment of Change. All predictors will
be checked for collinearity. Univariate logistic regression
will be performed on all potential predictors and those
associated with the outcomes will be entered into the
multivariate logistic regression model and backward
regression will be performed. Variables with the lowest
predictive value will be removed from the model if p >
0.05. Odds ratios and 95% confidence intervals will be
calculated for all final predictors.
Discussion
This paper outlines the protocol for a multicentre RCT
that will compare the effect of a combination of manual
therapy and exercise therapy, exercise therapy only and a
waiting-list control on physical function in osteoarthritis
of the hip. A multicentre approach was chosen to maxi-
mize the sample size and to improve generalisability of
the results. This study is in keeping with Meinert's defini-
tion of multi-centre, where the data are acquired from two
or more settings that are organizationally independent, a
common intervention and data-collection protocol are
used, and data management and analysis are centralized
[94]. Although the setting of the four centres is similar,
there may be differences in the demographic and socioe-
conomic profile between the sites, which are located in
different geographical areas within an urban setting.
A number of methodological elements have been
included in the trial to minimize bias such as power cal-
culation, randomization, concealed allocation, blinded
outcome assessment and intention-to-treat analysis. The
reporting of the study will be in keeping with CONSORT
guidelines [51], including recent recommendations for
the reporting of non-pharmacological studies [52].
A distinctive feature of the study is the inclusion of a wait-
ing-list control group. This is a variation of a cross-over
trial, where the participants in the control group are
crossed over to one of the intervention groups after the 9
week follow-up assessment. This design was chosen, as
one of the inclusion criteria for participation in the trial
was that all subjects must have been referred for physio-
therapy, and consequently must receive treatment. As the
waiting times for physiotherapy at the four participating
sites can vary between 6–12 weeks, this waiting-list con-
BMC Musculoskeletal Disorders 2009, 10:9 http://www.biomedcentral.com/1471-2474/10/9
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trol group will not be unduly compromised in their wait-
ing times for treatment. A true control group can result in
higher dropouts as patient expectations are not met and
implementing a cross-over design may help to reduce
dropout rates in studies investigating chronic diseases
such as arthritis [95]. The decision to include a control
group was made because, although exercise therapy has
been shown to have a positive short term effect on pain
and function in hip OA, the specific exercise protocol in
this study has not previously been investigated. Both exer-
cise and manual therapy protocols are based on current
clinical practice identified through questionnaire survey
[19] and therefore should be easily implemented in a clin-
ical setting. The waiting-list control group will improve
the scientific rigour of the study and allows more definite
conclusions to be made regarding the effect of the two
interventions under investigation. The control group
patients will be re-randomised into one of the two inter-
vention groups after the 9 week follow-up. A similar
design was used by Fransen et al [91,96]. Statistical analy-
ses will be conducted on the two intervention groups,
with and without the re-randomised control group sub-
jects, to assess the effect of the 9 week waiting period on
outcomes.
A combination of self-report and physical outcome meas-
ures will be used, all of which are easy to administer in a
standardized manner across the four sites.
A secondary aim of this trial is to ascertain the effect of a
number of baseline variables on treatment outcome of the
two interventions under investigation. Effect of treatment
may be different for patients with specific characteristics.
Identification of factors that affect treatment response is
increasingly being recognized as an important aspect of
physiotherapy management as it may facilitate the devel-
opment of more tailored rehabilitation regimes [97-99].
This is particularly relevant in OA which is described as a
heterogenous condition [100]. The EULAR evidence-
based recommendations for the management of hip OA
identified that clinical predictors of response to pharma-
cological and non-pharmacological interventions for hip
OA was one of 10 future research topics which should be
undertaken [22].
In summary, this multi centre RCT will be undertaken to
compare the effect of a combination of manual therapy
and exercise therapy, exercise therapy only, and a waiting-
list control on physical function in hip OA. High quality
methodology will be used in keeping with CONSORT
guidelines. The results of the study should inform clinical
practice and add to the evidence base for physiotherapy-
based interventions in hip OA.
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